Product Images Neostigmine Methylsulfate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 8 images provide visual information about the product associated with Neostigmine Methylsulfate NDC 0641-6150 by Hikma Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - neostigmine methylsulfate injection anda 1

logo - neostigmine methylsulfate injection anda 2

NDC 0641-6150-01 Rx only Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) FOR INTRAVENOUS USE 10 mL Multiple Dose Vial Each mL contains Neostigmine Methylsulfate 0.5 mg, Phenol 4.5 mg (used as a preservative), Sodium Acetate Trihydrate 0.2 mg, Water for Injection; pH adjusted, when necessary, with Sodium Hydroxide/Acetic Acid. Usual Dosage: See package insert. Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. PROTECT FROM LIGHT. Store in carton until time of use. - neostigmine methylsulfate injection anda 3

Neostigmine Methylsulfate Injection is a medication used for intravenous use. Each 10 mL multidose vial contains 5 mg of Neostigmine Methylsulfate Injection, USP with a concentration of 0.5 mg/mL. The solution contains Neostigmine Methylsulfate 0.5 mg, Ethanol 5% (w/v) as a stabilizer, Sodium Acetate Trihydrate 2 mg, and Water for Injection. The solution must be adjusted with Sodium Hydroxide and Hydrochloric Acid if necessary. The package insert contains the usual dosage instructions. The solution should be stored between 20°C to 25°C. The medication should be kept in a controlled room temperature and protected from light until the time of use. This medication is manufactured by Hikma.*

0.5 mg/mL 10 x 10 shelfpack - neostigmine methylsulfate injection anda 4

This is a medication label for Neostigmine Methylsulfate Injection, USP with a concentration of 5mg per 10mL used for intravenous administration. The label also provides information such as manufacturer, controlled temperature range, and tamper-proof seal. Usual dosage information is not available.*

NDC 0641-6150-25 Rx only Neostigmine Methylsulfate Injection, USP 5 mg/10 mL (0.5 mg/mL) FOR INTRAVENOUS USE 25 x 10 mL Multiple Dose Vials Each mL contains Neostigmine Methylsulfate 0.5 mg, Phenol 4.5 mg (used as a preservative), Sodium Acetate Trihydrate 0.2 mg, Water for Injection; pH adjusted, when necessary, with Sodium Hydroxide/Acetic Acid. Usual Dosage: See package insert. Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. PROTECT FROM LIGHT. Store in carton until time of use. - neostigmine methylsulfate injection anda 5

Each L container of the product with code DG 0541-6148-01 contains 5mg of Neostigmine Mty Timg and Phanol as a preservative. Neostigmine is a medication used to treat muscle weakness and can be used intravenously. The dosage should be determined by a healthcare professional and the product should be stored in a controlled room temperature environment. The product is manufactured in Eatcatown, NJ 07724. No additional information is available due to unclear text.*

NDC 0641-6149-01 Rx only Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) FOR INTRAVENOUS USE 10 mL Multiple Dose Vial Each mL contains Neostigmine Methylsulfate 1 mg, Phenol 4.5 mg (used as a preservative), Sodium Acetate Trihydrate 0.2 mg, Water for Injection; pH adjusted, when necessary, with Sodium Hydroxide/Acetic Acid. Usual Dosage: See package insert. Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. PROTECT FROM LIGHT. Store in carton until time of use. - neostigmine methylsulfate injection anda 6

This is a medication called Neostigmine Methylsulfate, which is delivered via injection and comes in vials containing 10mg of medication per 10mL of solution. It is meant for intravenous use only. The vials are for multiple doses and should be stored at room temperature between 20-25°C (60-77°F), and protected from light. There are no details on the typical dosage(s) included in this text.*

1 mg/mL 10 x 10 shelfpack - neostigmine methylsulfate injection anda 7

ADC 0BI1.6149.25 is an injection containing 10mg of Neostigmine with Methyisultate Felba L. It is intended for intravenous use and comes in a 10mL multi-dose vial. The pH level is 3. It is used for treatment and should be administered by a medical professional only.*

NDC 0641-6149-25 Rx only Neostigmine Methylsulfate Injection, USP 10 mg/10 mL (1 mg/mL) FOR INTRAVENOUS USE 25 x 10 mL Multiple Dose Vials Each mL contains Neostigmine Methylsulfate 1 mg, Phenol 4.5 mg (used as a preservative), Sodium Acetate Trihydrate 0.2 mg, Water for Injection; pH adjusted, when necessary, with Sodium Hydroxide/Acetic Acid. Usual Dosage: See package insert. Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. PROTECT FROM LIGHT. Store in carton until time of use. - neostigmine methylsulfate injection anda 8

This text contains product information including the Global Trade Item Number (GTIN), serial number (SN), expiration date (EXP), and lot number (LOT). The actual product or item associated with this information is not available.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.